$ 138.52
Key Takeaways
Risk factor
Strong trading liquidity
Profitability factor
Very low or no dividends
About
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement disorders; and in oncology, including hematologic and solid...
Company Valuation
From both historical and forecast perspectives, the stock is moderately underpriced compared to similar stocks. Specifically, the stock is fairly valued on P/E, neutral o
Target Price
The average target price of JAZZ is 175 and suggests 26% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increas
